Staffan Normark

Title: The Innovative Contributions of Staffan Normark

Introduction

Staffan Normark is a prominent inventor based in Stockholm, Sweden. He has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of 6 patents to his name, Normark's work has the potential to impact public health positively.

Latest Patents

Among his latest patents is a groundbreaking immunogenic composition that comprises bacterial membrane vesicles (MVs) featuring a streptococcal MalX antigen and/or a streptococcal PrsA antigen. This composition is characterized by the absence of an immunogenic amount of a streptococcal PspA antigen. The membrane vesicles may also be artificial membrane particles, which have medical applications, particularly for immunization against pneumococcal disease. Another notable patent involves isolated membrane vesicle microparticles (MPs) that include specific proteins at defined levels, which are crucial for immunization purposes. These innovations highlight Normark's commitment to advancing vaccine technology.

Career Highlights

Throughout his career, Staffan Normark has worked with various companies, including Zalvac AB. His expertise in immunology and vaccine development has positioned him as a key figure in the field. His patents reflect a deep understanding of the complexities involved in creating effective immunogenic compositions.

Collaborations

Normark has collaborated with notable individuals in his field, including Thomas Boren and Anna Arnqvist. These partnerships have likely contributed to the success of his innovative projects and patents.

Conclusion

Staffan Normark's contributions to vaccine development and immunology are noteworthy. His innovative patents and collaborations demonstrate his dedication to improving public health through scientific advancements.